Prescription opioids induced microbial dysbiosis worsens severity of chronic pancreatitis and drives pain hypersensitivity

References

• Majumder S, Chari ST. Chronic pancreatitis. Lancet. 2016;387(10031):1957–18. doi:10.1016/S0140-6736(16)00097-0.
   PubMed Web of Science ®Google Scholar
• Pham A, Forsmark C. Chronic pancreatitis: review and update of etiology, risk factors, and management. FResearch. 2018;7:607. doi:10.12688/f1000research.12852.1.
   Google Scholar
• Frost F, Weiss FU, Sendler M, Kacprowski T, Rühlemann M, Bang C, Franke A, Völker U, Völzke H, Lamprecht G. et al. The gut microbiome in patients with chronic pancreatitis is characterized by significant dysbiosis and overgrowth by opportunistic pathogens. Clin Transl Gastroenterol. 2020;11(9):11. doi:10.14309/ctg.0000000000000232.
   Web of Science ®Google Scholar
• Kleeff J, Whitcomb DC, Shimosegawa T, Esposito I, Lerch MM, Gress T, Mayerle J, Drewes AM, Rebours V, Akisik F. et al. Chronic pancreatitis. Nat Rev Dis Primers. 2017;3(1):17060. doi:10.1038/nrdp.2017.60.
   PubMed Web of Science ®Google Scholar
• Anekar AA, Cascella M. WHO analgesic ladder. StatPearls [Internet]. St. Petersburg, Florida, United States: StatPearls Publishing; 2021.
   Google Scholar
• Olesen SS, Juel J, Graversen C, Kolesnikov Y, Wilder-Smith OH, Drewes AM. Pharmacological pain management in chronic pancreatitis. World J Gastroenterol: WJG. 2013;19(42):7292. doi:10.3748/wjg.v19.i42.7292.
   Web of Science ®Google Scholar
• Bilal M, Chatila A, Siddiqui MT, Al-Hanayneh M, Shah AR, Desai M, Wadhwa V, Parupudi S, Casey BW, Krishnan K. et al. Rising prevalence of opioid use disorder and predictors for opioid use disorder among hospitalized patients with chronic pancreatitis. Pancreas. 2019;48(10):1386–92. doi:10.1097/MPA.0000000000001430.
   PubMed Web of Science ®Google Scholar
• Brush DE. Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-Induced Hyperalgesia. J Med Toxicol. 2012;8(4):387–392. doi:10.1007/s13181-012-0260-0.
   PubMedGoogle Scholar
• Brock C, Olesen SS, Olesen AE, Frøkjaer JB, Andresen T, Drewes AM. Opioid-induced bowel dysfunction. Drugs. 2012;72(14):1847–65. doi:10.2165/11634970-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Jalodia R, Abu YF, Oppenheimer MR, Herlihy B, Meng J, Chupikova I, Tao J, Ghosh N, Dutta RK, Kolli U. et al. Opioid use, Gut Dysbiosis, inflammation, and the nervous system. J Neuroimmune Pharmacol. 2022;17(1–2):76–93. doi:10.1007/s11481-021-10046-z.
   Web of Science ®Google Scholar
• Wang F, Roy S. Gut homeostasis, microbial dysbiosis, and opioids. Toxicol Pathol. 2017;45(1):150–6. doi:10.1177/0192623316679898.
   PubMed Web of Science ®Google Scholar
• Tao J, Cheema H, Kesh K, Dudeja V, Dawra R, Roy S. Chronic pancreatitis in a caerulein-induced mouse model is associated with an altered gut microbiome. Pancreatology. 2022;22(1):30–42. doi:10.1016/j.pan.2021.12.003.
   Web of Science ®Google Scholar
• Zhou C-H, Meng Y-T, Xu J-J, Fang X, Zhao J-L, Zhou W, Zhao J, Han J-C, Zhang L, Wang K-X. et al. Altered diversity and composition of gut microbiota in Chinese patients with chronic pancreatitis. Pancreatology. 2020;20(1):16–24. doi:10.1016/j.pan.2019.11.013.
   Web of Science ®Google Scholar
• Han M-M, Zhu X-Y, Peng Y-F, Lin H, Liu D-C, Li L. The alterations of gut microbiota in mice with chronic pancreatitis. Ann Transl Med. 2019;7(18):464–464. doi:10.21037/atm.2019.08.18.
   Web of Science ®Google Scholar
• Brubaker L, Luu S, Hoffman K, Wood A, Navarro Cagigas M, Yao Q, Petrosino J, Fisher W, Van Buren G. Microbiome changes associated with acute and chronic pancreatitis: a systematic review. Pancreatology. 2021;21(1):1–14. doi:10.1016/j.pan.2020.12.013.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Sindberg G, Wang F, Meng J, Sharma U, Zhang L, Dauer P, Chen C, Dalluge J, Johnson T. et al. Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunol. 2016;9(6):1418–28. doi:10.1038/mi.2016.9.
   PubMed Web of Science ®Google Scholar
• Martel J, Chang S-H, Ko Y-F, Hwang T-L, Young JD, Ojcius DM. Gut barrier disruption and chronic disease. Trends Endocrinol Metabolism. 2022;33(4):247–265. doi:10.1016/j.tem.2022.01.002.
   PubMed Web of Science ®Google Scholar
• Barlass U, Dutta R, Cheema H, George J, Sareen A, Dixit A, Yuan Z, Giri B, Meng J, Banerjee S. et al. Morphine worsens the severity and prevents pancreatic regeneration in mouse models of acute pancreatitis. Gut. 2017;67:600–602. doi: 10.1136/gutjnl-2017-313717.
   Web of Science ®Google Scholar
• Bálint ER, Fűr G, Kui B, Balla Z, Kormányos ES, Orján EM, Tóth B, Horváth G, Szűcs E, Benyhe S. et al. Fentanyl but not morphine or buprenorphine improves the severity of necrotizing acute pancreatitis in rats. Int J Mol Sci. 2022;23(3):1192. doi:10.3390/ijms23031192.
   Web of Science ®Google Scholar
• Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. J Am Soc Anesthesiol. 2006;104(3):570–587. doi:10.1097/00000542-200603000-00025.
   PubMed Web of Science ®Google Scholar
• Brubaker L, Luu S, Hoffman K, Wood A, Cagigas MN, Yao Q, Petrosino J, Fisher W, Van Buren G. Microbiome changes associated with acute and chronic pancreatitis: a systematic review. Pancreatology. 2021;21(1):1–14. doi:10.1016/j.pan.2020.12.013.
   PubMed Web of Science ®Google Scholar
• Ammer-Herrmenau C, Pfisterer N, Weingarten MF, Neesse A. The microbiome in pancreatic diseases: recent advances and future perspectives. United Eur Gastroenterol J. 2020;8(8):878–885. doi:10.1177/2050640620944720.
   Web of Science ®Google Scholar
• Akshintala VS, Talukdar R, Singh VK, Goggins M. The gut microbiome in pancreatic disease. Clin Gastroenterol Hepatol. 2019;17(2):290–5. doi:10.1016/j.cgh.2018.08.045.
   PubMed Web of Science ®Google Scholar
• Jandhyala SM, Madhulika A, Deepika G, Rao GV, Reddy DN, Subramanyam C, Sasikala M, Talukdar R. Altered intestinal microbiota in patients with chronic pancreatitis: implications in diabetes and metabolic abnormalities. Sci Rep. 2017;7(1):1–10. doi:10.1038/srep43640.
   Google Scholar
• Talukdar R, Sarkar P, Jakkampudi A, Sarkar S, Aslam M, Jandhyala M, Deepika G, Unnisa M, Reddy DN. The gut microbiome in pancreatogenic diabetes differs from that of type 1 and type 2 diabetes. Sci Rep. 2021;11(1):1–12. doi:10.1038/s41598-021-90024-w.
   Web of Science ®Google Scholar
• Capurso G, Lahner E. The interaction between smoking, alcohol and the gut microbiome. Best Pract Res Clin Gastroenterol. 2017;31(5):579–88. doi:10.1016/j.bpg.2017.10.006.
   PubMed Web of Science ®Google Scholar
• McEachron KR, Nalluri H, Beilman GJ, Kirchner VA, Pruett TL, Freeman ML, Trikudanathan G, Staley C, Bellin MD. Decreased intestinal microbiota diversity is associated with increased gastrointestinal symptoms in patients with chronic pancreatitis. Pancreas. 2022;51(6):649–656. doi:10.1097/MPA.0000000000002096.
   Web of Science ®Google Scholar
• Ciocan D, Rebours V, Voican CS, Wrzosek L, Puchois V, Cassard A-M, Perlemuter G. Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis. Sci Rep. 2018;8(1):1–12. doi:10.1038/s41598-018-23146-3.
   Google Scholar
• Thomas RM, Gharaibeh RZ, Gauthier J, Beveridge M, Pope JL, Guijarro MV, Yu Q, He Z, Ohland C, Newsome R. et al. Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models. Carcinogenesis. 2018;39(8):1068–78. doi:10.1093/carcin/bgy073.
   PubMed Web of Science ®Google Scholar
• Lagkouvardos I, Pukall R, Abt B, Foesel BU, Meier-Kolthoff JP, Kumar N, Bresciani A, Martínez I, Just S, Ziegler C. et al. The mouse intestinal bacterial collection (miBC) provides host-specific insight into cultured diversity and functional potential of the gut microbiota. Nat Microbiol. 2016;1(10):16131. doi:10.1038/nmicrobiol.2016.131.
   PubMed Web of Science ®Google Scholar
• Dobranowski PA, Tang C, Sauvé JP, Menzies SC, Sly LM. Compositional changes to the ileal microbiome precede the onset of spontaneous ileitis in SHIP deficient mice. Gut Microbes. 2019;10(5):578–98. doi:10.1080/19490976.2018.1560767.
   PubMed Web of Science ®Google Scholar
• Davoren MJ, Liu J, Castellanos J, Rodríguez-Malavé NI, Schiestl RH. A novel probiotic, lactobacillus johnsonii 456, resists acid and can persist in the human gut beyond the initial ingestion period. Gut Microbes. 2019;10(4):458–80. doi:10.1080/19490976.2018.1547612.
   PubMed Web of Science ®Google Scholar
• Cruchet S, Obregon MC, Salazar G, Diaz E, Gotteland M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition. 2003;19(9):716–21. doi:10.1016/S0899-9007(03)00109-6.
   PubMed Web of Science ®Google Scholar
• Marteau P, Lémann M, Seksik P, Laharie D, Colombel JF, Bouhnik Y. et al. Ineffectiveness of lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial. Gut. 2006;55:842–7. doi: 10.1136/gut.2005.076604.
   PubMed Web of Science ®Google Scholar
• Pridmore RD, Pittet A-C, Praplan F, Cavadini C. Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity. FEMS Microbiol Lett. 2008;283(2):210–5. doi:10.1111/j.1574-6968.2008.01176.x.
   PubMed Web of Science ®Google Scholar
• T-B B, Wen J, Zhao Y-C, Tian S-J, Zhang X-Y, Wang D-H. Bifidobacterium pseudolongum reduces triglycerides by modulating gut microbiota in mice fed high-fat food. J Steroid Biochem Mol Biol. 2020;198:105602. doi:10.1016/j.jsbmb.2020.105602.
   Web of Science ®Google Scholar
• Guo W, Mao B, Cui S, Tang X, Zhang Q, Zhao J, Zhang H. Protective effects of a novel probiotic bifidobacterium pseudolongum on the intestinal barrier of colitis mice via modulating the Pparγ/STAT3 pathway and intestinal microbiota. Foods. 2022;11(11):1551. doi:10.3390/foods11111551.
   Web of Science ®Google Scholar
• Ma B, Gavzy SJ, Saxena V, Song Y, Piao W, Lwin HW, Lakhan R, Iyyathurai J, Li L, France M. et al. Strain-specific alterations in gut microbiome and host immune responses elicited by tolerogenic Bifidobacterium pseudolongum. Sci Rep. 2023;13(1):1023. doi:10.1038/s41598-023-27706-0.
   PubMed Web of Science ®Google Scholar
• Salavrakos M, Leclercq S, De Timary P, Dom G. Microbiome and substances of abuse. Prog Neuropsychopharmacol Biol Psychiatry. 2021;105:110113. doi:10.1016/j.pnpbp.2020.110113.
   Web of Science ®Google Scholar
• Jalodia R, Abu YF, Oppenheimer MR, Herlihy B, Meng J, Chupikova I, Tao J, Ghosh N, Dutta RK, Kolli U. et al. Opioid use, gut dysbiosis, inflammation, and the nervous system. J Neuroimmune Pharm. 2022;17(1–2):1–18. doi:10.1007/s11481-021-10046-z.
   Web of Science ®Google Scholar
• Meng J, Yu H, Ma J, Wang J, Banerjee S, Charboneau R, Barke RA, Roy S. Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner. PloS ONE. 2013;8(1):e54040. doi:10.1371/journal.pone.0054040.
   PubMed Web of Science ®Google Scholar
• Meng J, Banerjee S, Zhang L, Sindberg G, Moidunny S, Li B, Robbins DJ, Girotra M, Segura B, Ramakrishnan S. et al. Opioids impair intestinal epithelial repair in HIV-infected humanized mice. Front Immunol. 2020;10:2999. doi: 10.3389/fimmu.2019.02999.
   Web of Science ®Google Scholar
• Ahuja M, Schwartz DM, Tandon M, Son A, Zeng M, Swaim W, Eckhaus M, Hoffman V, Cui Y, Xiao B. et al. Orai1-mediated antimicrobial secretion from pancreatic acini shapes the gut microbiome and regulates gut innate immunity. Cell Metab. 2017;25(3):635–46. doi:10.1016/j.cmet.2017.02.007.
   PubMed Web of Science ®Google Scholar
• Ghosh N, Kesh K, Singh PK, Sharma U, Chupikova I, Ramakrishnan S, Roy S. Morphine use induces gastric microbial dysbiosis driving gastric inflammation through TLR2 signaling which is attenuated by proton pump inhibitor. Br J Pharmacol. 2022;12:1582–1596. doi:10.1111/bph.16025.
   Web of Science ®Google Scholar
• Bava EP, George J, Iyer S, Sahay P, Tarique M, Jain T, Vaish U, Giri B, Sharma P, Saluja AK. et al. Pirfenidone ameliorates chronic pancreatitis in mouse models through immune and cytokine modulation. Pancreatology. 2022;22(5):553–63. doi:10.1016/j.pan.2022.05.002.
   Web of Science ®Google Scholar
• Deuis JR, Dvorakova LS, Vetter I. Methods used to evaluate pain behaviors in rodents. Front Mol Neurosci. 2017;10:284. doi:10.3389/fnmol.2017.00284.
   PubMed Web of Science ®Google Scholar
• Bushnell B. BBDuk Guide. DOE Joint Genome Institute. https://jgi.doe.gov/data-and-tools/software-tools/bbtools/bb-tools-user-guide/bbduk-guide/, 2021.
   Google Scholar
• Consortium TU, Martin M-J, Orchard S, Magrane M, Agivetova R, Ahmad S, Alpi E, Bowler-Barnett EH, Britto R, Bursteinas B. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49:D480–D9. doi:10.1093/nar/gkaa1100.
   PubMed Web of Science ®Google Scholar
• Franzosa EA, McIver LJ, Rahnavard G, Thompson LR, Schirmer M, Weingart G, Lipson KS, Knight R, Caporaso JG, Segata N. et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods. 2018;15(11):962–8. doi:10.1038/s41592-018-0176-y.
   PubMed Web of Science ®Google Scholar
• Caspi R, Billington R, Fulcher CA, Keseler IM, Kothari A, Krummenacker M, Latendresse M, Midford PE, Ong Q, Ong WK. et al. The MetaCyc database of metabolic pathways and enzymes. Nucleic Acids Res. 2018;46(D1):D633–D9. doi:10.1093/nar/gkx935.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30. doi:10.1093/nar/28.1.27.
   PubMed Web of Science ®Google Scholar
• Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, Lewis S. et al. AmiGO: online access to ontology and annotation data. Bioinformatics. 2009;25(2):288–9. doi:10.1093/bioinformatics/btn615.
   PubMed Web of Science ®Google Scholar
• Chong J, Liu P, Zhou G, Xia J. Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data. Nat Protoc. 2020;15(3):799–821. doi:10.1038/s41596-019-0264-1.
   PubMed Web of Science ®Google Scholar
• Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U. et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Cereb Blood Flow Metab. 2020;40(9):1769–1777. doi:10.1177/0271678X20943823.
   PubMed Web of Science ®Google Scholar